Thromboxane modulating agents. 1. Design of 1-[(arylsulfonyl)amino] alkylindole derivatives as dual thromboxane synthase inhibitor/thromboxane receptor antagonists.
- 21 December 1995
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 5 (24) , 3017-3022
- https://doi.org/10.1016/0960-894x(95)00529-4
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Comparison of the disposition of two novel combined thromboxane synthase inhibitors/thromboxane A2receptor antagonists in the isolated perfused rat liverXenobiotica, 1995
- Recent progress in the clinical development of thromboxane A2receptor antagonistsExpert Opinion on Investigational Drugs, 1994
- Novel antithrombotic agents with combined thromboxane receptor antagonist (TxRA)/thromboxane synthase inhibitor (TxSI) activitiesDrugs of the Future, 1994
- Thromboxane A2 receptor antagonistsMedicinal Research Reviews, 1991
- Role of proaggregatory and antiaggregatory prostaglandins in hemostasis. Studies with combined thromboxane synthase inhibition and thromboxane receptor antagonism.Journal of Clinical Investigation, 1987
- Selective thromboxane synthetase inhibitors. 4. 2-(1H-Imidazol-1-ylmethyl)benzo[b]furan-, -benzo[b]thiophene-, -indole- and -naphthalenecarboxylic acidsJournal of Medicinal Chemistry, 1986
- The biochemical pharmacology of thromboxane synthase inhibition in man.Circulation, 1985
- Selective thromboxane synthetase inhibitors. 1. 1-[(Aryloxy)alkyl]-1H-imidazolesJournal of Medicinal Chemistry, 1985
- Platelet and Blood Vessel Arachidonate Metabolism and InteractionsJournal of Clinical Investigation, 1979
- Diversion of prostaglandin endoperoxide metabolism by selective inhibition of thromboxane A2 biosynthesis in lung, spleen or plateletsEuropean Journal of Pharmacology, 1977